Company Filing History:
Years Active: 2018-2025
Title: Elisabetta Traggiai: Innovator in Antibody Research
Introduction
Elisabetta Traggiai is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of antibody research, particularly in the development of therapies for viral infections. With a total of 10 patents to her name, her work has the potential to impact public health positively.
Latest Patents
Among her latest patents are innovations related to hepatitis B and polyomavirus. The first patent focuses on anti-HBsAg antibodies, antibody fragments, and their applications for the prevention and treatment of hepatitis B virus infection and associated diseases. The second patent involves anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and related conditions.
Career Highlights
Elisabetta Traggiai is currently employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field and contribute to groundbreaking research in immunology and virology.
Collaborations
Some of her notable coworkers include Johanna Abend and Zorica Dragic. Their combined expertise enhances the research environment and fosters innovation within their projects.
Conclusion
Elisabetta Traggiai's work in antibody research exemplifies the vital role of inventors in advancing medical science. Her patents not only showcase her innovative spirit but also hold promise for future therapeutic developments.